雇用者と職場の薬物検査の世界市場

雇用者と職場の薬物検査の世界市場は2030年までに米国で144億米ドルに達する見込み

2024年に120億米ドルと推定される雇用者と職場の薬物検査の世界市場は、2024年から2030年にかけてCAGR 3.2％で成長し、2030年には144億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである雇用前薬物スクリーニングは、CAGR 3.2%を記録し、分析期間終了までに93億米ドルに達すると予測されます。雇用後セグメントの成長率は、分析期間中CAGR 3.2%と推定されます。

米国市場は33億米ドル、中国はCAGR6.0％で成長予測

米国の雇用者と職場の薬物検査市場は、2024年に33億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに29億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.2%と2.4%と予測されています。欧州では、ドイツがCAGR 1.8%で成長すると予測されています。

世界の雇用者と職場の薬物検査市場- 主要動向と促進要因のまとめ

なぜ雇用者と職場の薬物検査がワークフォースマネジメントに不可欠なのか？

雇用者と職場の薬物検査は、労働力の安全性、生産性、業界規制の遵守に欠かせない要素となっています。薬物乱用に関連するリスクを軽減し、安全で効率的な職場環境を確保するために、様々な分野の組織が薬物検査プログラムを導入しています。運輸、建設、ヘルスケア、製造業など、職場の安全が最優先される業界では、事故防止、業務効率の向上、米国運輸省（DOT）、労働安全衛生局（OSHA）、「薬物のない職場法（Drug-Free Workplace Act）」などの規制遵守のため、厳格な薬物検査方針を定めています。

オピオイドの乱用、マリファナの合法化、合成麻薬の消費など、薬物誤用の蔓延が拡大しているため、強固な薬物スクリーニング・ソリューションの必要性が高まっています。雇用主は、従業員や求職者の薬物使用を検出するために、尿検査、唾液検査、毛包検査、血液検査など、さまざまな検査方法を利用しています。さらに、迅速かつ現場での検査技術の進歩により、雇用主は即座にスクリーニングを実施できるようになり、結果までの所要時間が短縮されました。職場の健康と生産性にますます注目が集まる中、企業は無作為、雇用前、事故後、職務復帰後の薬物検査プログラムを統合し、より安全でコンプライアンスに準拠した労働力を確保しています。

テクノロジーはどのように進歩しているか？

テクノロジーの進歩は、薬物検査の方法を大きく変え、より効率的で、正確で、利用しやすいものにしました。最も注目すべき技術革新のひとつは、口腔液（唾液）や呼気分析ベースの薬物検出システムなど、非侵襲的で迅速な薬物検査ソリューションの開発です。これらの方法はすぐに結果を出し、実験室ベースの尿検査の必要性をなくし、雇用者と従業員双方の利便性を向上させる。さらに、AI主導の薬物スクリーニング・プラットフォームは、サンプルの認証とデータの精度を高め、偽陽性やサンプルの改ざんの可能性を減らしています。

携帯型・デジタル薬物検査機器の台頭により、特に航空、物流、公安など安全性が重視される業界では、その場での検査が可能になりました。クラウドベースの薬物検査管理ソフトウェアは、薬物検査プログラムの管理をさらに合理化し、雇用主がコンプライアンスを追跡し、スケジュールを自動化し、リアルタイムのレポートを作成することを可能にしました。さらに、バイオマーカーに基づく検査や遺伝子スクリーニングの進歩により、個別化された薬物スクリーニング・ソリューションへの道が開かれ、企業は従業員の特定物質に対する代謝反応を評価できるようになっています。規制の枠組みが進化するにつれて、安全で透明性の高い薬物検査結果管理のためのブロックチェーン技術の採用も普及しており、データの完全性とコンプライアンスが確保されています。

職場の薬物検査の需要を牽引している業界は？

雇用者と職場の薬物検査の需要は、運輸、建設、ヘルスケア、製造、政府機関など、安全性が重視される業界で最も高まっています。特にトラック輸送、航空輸送、鉄道輸送などの運輸部門では、連邦政府が薬物検査を義務付けており、企業は雇用前、無作為、事故後のスクリーニングを実施する必要があります。重機の操作が日常的に必要な建設業や製造業では、労働災害や賠償リスクを防ぐために薬物検査プログラムに依存しています。

ヘルスケア部門も職場薬物検査の主要な採用企業であり、医療従事者、看護師、救急隊員が患者や重要な処置を扱う際に支障がないことを保証しています。政府機関、法執行機関、軍事組織は、国家安全保障と公共の安全を維持するために、厳格な薬物スクリーニング・ポリシーを持っています。さらに、金融、IT、小売の企業雇用主は、特にリモートワークやハイブリッドワークモデルが従業員の健康状態やパフォーマンスを監視する上で新たな課題をもたらす中、薬物フリー職場ポリシーを導入しています。職場の安全性とコンプライアンス基準が進化し続ける中、業界を問わず包括的な薬物検査プログラムに対する需要は大きく伸びると予想されます。

雇用者と職場の薬物検査市場の成長の原動力は？

雇用者と職場の薬物検査市場の成長は、薬物乱用の蔓延、規制遵守要件の増加、薬物スクリーニング方法の技術的進歩など、いくつかの要因によってもたらされます。オピオイド危機や様々な地域における娯楽用・医療用マリファナの合法化により、企業はより厳格な薬物検査方針を採用するようになり、職場の安全性と生産性が確保されています。さらに、無作為検査や事故後の薬物検査プログラムの拡大により、迅速かつ費用対効果の高いスクリーニング・ソリューションの必要性が高まっています。

AIを活用した薬物検査分析、ポータブル・スクリーニング・デバイス、リアルタイム・レポーティング・プラットフォームの採用は、職場の薬物検査をさらに合理化し、より効率的でスケーラブルなものにしています。企業が欠勤、労働災害、法的責任に関連するリスクを軽減しようとしているためです。生体認証ベースの薬物検査ソリューション、ブロックチェーンを活用した薬物検査報告、デジタル薬物スクリーニング・プラットフォームの統合により、職場の薬物検査プログラムの正確性、安全性、コンプライアンスが強化されると期待されています。組織が労働者の健康と安全を優先する中、調査手法の革新と規制枠組みの進化により、雇用者と職場の薬物検査市場は継続的な拡大が見込まれています。

セグメント

製品タイプ（雇用前薬物スクリーニング、雇用後薬物スクリーニング）、製品（消耗品、機器、迅速検査機器、サービス）、薬物（アルコール、大麻／マリファナ、コカイン、オピオイド、アンフェタミン＆メタンフェタミン、LSD、その他）、最終用途（IT／金融、製造、運輸、建設、小売＆ホスピタリティ、ヘルスケア、教育、その他専門サービス）

調査対象企業の例

• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Clinical Reference Laboratory, Inc.
• Cordant Health Solutions
• DISA Global Solutions
• Dragerwerk AG & Co. KGaA
• Express Diagnostics International, Inc.
• F. Hoffmann-La Roche Ltd
• HireRight, LLC
• Laboratory Corporation of America Holdings（Labcorp）
• Medtox Scientific, Inc.
• Omega Laboratories, Inc.
• OraSure Technologies, Inc.
• Premier Biotech, Inc.
• Psychemedics Corporation
• Quest Diagnostics Incorporated
• Randox Testing Services
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• United States Drug Testing Laboratories Inc.（USDTL）

AIインテグレーションズ

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Employer and Workplace Drug Testing Market to Reach US$14.4 Billion by 2030

The global market for Employer and Workplace Drug Testing estimated at US$12.0 Billion in the year 2024, is expected to reach US$14.4 Billion by 2030, growing at a CAGR of 3.2% over the analysis period 2024-2030. Pre-employment Drug Screens, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$9.3 Billion by the end of the analysis period. Growth in the Post-employment segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 6.0% CAGR

The Employer and Workplace Drug Testing market in the U.S. is estimated at US$3.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 6.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Employer and Workplace Drug Testing Market - Key Trends & Drivers Summarized

Why Is Employer and Workplace Drug Testing Essential for Workforce Management?

Employer and workplace drug testing has become a critical component of workforce safety, productivity, and compliance with industry regulations. Organizations across various sectors implement drug testing programs to mitigate the risks associated with substance abuse, ensuring a safe and efficient work environment. Industries such as transportation, construction, healthcare, and manufacturing, where workplace safety is a top priority, have stringent drug testing policies to prevent accidents, enhance operational efficiency, and comply with regulatory mandates such as those from the U.S. Department of Transportation (DOT), Occupational Safety and Health Administration (OSHA), and the Drug-Free Workplace Act.

The growing prevalence of drug misuse, including the rise of opioid abuse, marijuana legalization, and synthetic drug consumption, has intensified the need for robust drug screening solutions. Employers utilize various testing methods, including urine, saliva, hair follicle, and blood tests, to detect substance use among employees and job candidates. Additionally, advancements in rapid and on-site testing technologies have enabled employers to conduct instant screening, reducing turnaround time for results. With an increasing focus on workplace health and productivity, businesses are integrating random, pre-employment, post-accident, and return-to-duty drug testing programs, ensuring a safer and more compliant workforce.

How Is Technology Advancing Employer and Workplace Drug Testing?

Technological advancements have significantly transformed drug testing methods, making them more efficient, accurate, and accessible. One of the most notable innovations is the development of non-invasive and rapid drug testing solutions, such as oral fluid (saliva) and breathalyzer-based drug detection systems. These methods provide immediate results and eliminate the need for laboratory-based urine testing, improving convenience for both employers and employees. Additionally, AI-driven drug screening platforms have enhanced sample authentication and data accuracy, reducing the likelihood of false positives or tampered samples.

The rise of portable and digital drug testing devices has enabled on-the-spot testing, particularly in safety-sensitive industries such as aviation, logistics, and public safety. Cloud-based drug testing management software has further streamlined the administration of drug testing programs, allowing employers to track compliance, automate scheduling, and generate real-time reports. Additionally, advancements in biomarker-based testing and genetic screening are paving the way for personalized drug screening solutions, enabling businesses to assess employees’ metabolic responses to specific substances. As regulatory frameworks evolve, the adoption of blockchain technology for secure and transparent drug test result management is also gaining traction, ensuring data integrity and compliance.

Which Industries Are Driving Demand for Workplace Drug Testing?

The demand for employer and workplace drug testing is strongest in safety-critical industries, including transportation, construction, healthcare, manufacturing, and government agencies. The transportation sector, particularly trucking, aviation, and rail, has federal drug testing mandates requiring companies to conduct pre-employment, random, and post-accident screenings. The construction and manufacturing industries, where heavy machinery operation is a daily requirement, rely on drug testing programs to prevent workplace accidents and liability risks.

The healthcare sector is another major adopter of workplace drug testing, ensuring that medical professionals, nurses, and emergency responders remain unimpaired while handling patients and critical procedures. Government agencies, law enforcement, and military organizations have stringent drug screening policies to maintain national security and public safety. Additionally, corporate employers in finance, IT, and retail have implemented substance-free workplace policies, especially as remote and hybrid work models introduce new challenges in monitoring employee wellness and performance. As workplace safety and compliance standards continue to evolve, the demand for comprehensive drug testing programs across industries is expected to grow significantly.

What Is Driving the Growth of the Employer and Workplace Drug Testing Market?

The growth in the employer and workplace drug testing market is driven by several factors, including the rising prevalence of substance abuse, increased regulatory compliance requirements, and technological advancements in drug screening methods. The opioid crisis and the legalization of recreational and medical marijuana in various regions have prompted businesses to adopt stricter drug testing policies, ensuring workplace safety and productivity. Additionally, the expansion of random and post-incident drug testing programs has increased the need for rapid and cost-effective screening solutions.

The adoption of AI-powered drug testing analytics, portable screening devices, and real-time reporting platforms has further streamlined workplace drug testing, making it more efficient and scalable. Government initiatives and corporate wellness programs promoting drug-free work environments have also fueled market growth, as businesses seek to mitigate risks associated with absenteeism, workplace accidents, and legal liabilities. The integration of biometric-based drug testing solutions, blockchain-backed drug test reporting, and digital drug screening platforms is expected to enhance the accuracy, security, and compliance of workplace drug testing programs. As organizations prioritize workforce health and safety, the employer and workplace drug testing market is poised for continued expansion, driven by innovations in testing methodologies and evolving regulatory frameworks.

SCOPE OF STUDY:

The report analyzes the Employer and Workplace Drug Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Pre-employment Drug Screens, Post-employment); Product (Consumables, Instruments, Rapid Testing Devices, Services); Drug (Alcohol, Cannabis / Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, Others); End-Use (IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education, Other Professional Services)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Clinical Reference Laboratory, Inc.
• Cordant Health Solutions
• DISA Global Solutions
• Dragerwerk AG & Co. KGaA
• Express Diagnostics International, Inc.
• F. Hoffmann-La Roche Ltd
• HireRight, LLC
• Laboratory Corporation of America Holdings (Labcorp)
• Medtox Scientific, Inc.
• Omega Laboratories, Inc.
• OraSure Technologies, Inc.
• Premier Biotech, Inc.
• Psychemedics Corporation
• Quest Diagnostics Incorporated
• Randox Testing Services
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• United States Drug Testing Laboratories Inc. (USDTL)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Employer and Workplace Drug Testing - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Workplace Safety Mandates Propel Adoption of Comprehensive Drug Testing Programs
  • Rising Substance Abuse Concerns Post-COVID Fuel Growth in Random and Pre-Employment Drug Screening
  • Expansion of DOT and Federally Mandated Testing Requirements Drives Market for Lab-Based Solutions
  • Legalization of Cannabis Creates Demand for More Sophisticated, Policy-Aligned Drug Testing Protocols
  • Digital Platforms and At-Home Kits Enable Scalable, Remote Workplace Drug Testing Capabilities
  • Integration of Drug Testing With Workforce Management Platforms Streamlines Compliance Reporting
  • Manufacturing and Construction Sectors Drive High-Volume Demand for Post-Incident Testing Services
  • Workplace Liability Concerns Encourage Proactive Screening in Safety-Critical Industries
  • Zero-Tolerance Corporate Cultures Sustain Long-Term Adoption of Multi-Panel Drug Testing Kits
  • Hair Follicle and Oral Fluid Tests Gain Traction for Extended Detection and Convenience
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Employer and Workplace Drug Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Employer and Workplace Drug Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Employer and Workplace Drug Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Pre-employment Drug Screens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Pre-employment Drug Screens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Pre-employment Drug Screens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Post-employment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Post-employment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Post-employment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Opioids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Opioids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Opioids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Amphetamine & Methamphetamine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Amphetamine & Methamphetamine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Amphetamine & Methamphetamine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for LSD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for LSD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for LSD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Alcohol by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Alcohol by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Alcohol by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Cannabis / Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Cannabis / Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Cannabis / Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Cocaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Cocaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Cocaine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for IT / Finance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for IT / Finance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for IT / Finance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Transportation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Construction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Construction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Construction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Retail & Hospitality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Retail & Hospitality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Retail & Hospitality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Education by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Education by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Education by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Other Professional Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Other Professional Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Other Professional Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 62: World Recent Past, Current & Future Analysis for Rapid Testing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 63: World Historic Review for Rapid Testing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: World 15-Year Perspective for Rapid Testing Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 65: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Employer and Workplace Drug Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 68: USA Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: USA 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: USA 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 74: USA Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: USA Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: USA 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 77: USA Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: USA Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: USA 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Canada 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 83: Canada Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Canada Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Canada 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 86: Canada Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Canada Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Canada 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 89: Canada Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Canada Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Canada 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• JAPAN
  • Employer and Workplace Drug Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 92: Japan Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Japan Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Japan 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 95: Japan Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Japan Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Japan 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 98: Japan Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Japan Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Japan 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 101: Japan Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Japan Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Japan 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• CHINA
  • Employer and Workplace Drug Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 104: China Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: China Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: China 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 107: China Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: China Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: China 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 110: China Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: China Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: China 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 113: China Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: China Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: China 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• EUROPE
  • Employer and Workplace Drug Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 117: Europe Historic Review for Employer and Workplace Drug Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Europe 15-Year Perspective for Employer and Workplace Drug Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 119: Europe Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Europe Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Europe 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 122: Europe Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Europe Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Europe 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 125: Europe Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Europe Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Europe 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 128: Europe Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Europe Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Europe 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• FRANCE
  • Employer and Workplace Drug Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 131: France Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: France Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: France 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 134: France Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: France Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: France 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 137: France Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: France Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: France 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 140: France Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: France Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: France 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• GERMANY
  • Employer and Workplace Drug Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 143: Germany Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Germany Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Germany 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 146: Germany Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Germany Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Germany 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 149: Germany Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Germany Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Germany 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 152: Germany Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Germany Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Germany 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 155: Italy Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Italy Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Italy 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 158: Italy Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Italy Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Italy 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 161: Italy Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Italy Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Italy 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 164: Italy Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Italy Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Italy 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Employer and Workplace Drug Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 167: UK Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: UK Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: UK 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 170: UK Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: UK Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: UK 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 173: UK Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: UK Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: UK 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 176: UK Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: UK Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: UK 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 179: Spain Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Spain Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Spain 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 182: Spain Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Spain Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Spain 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 185: Spain Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Spain Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Spain 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 188: Spain Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Spain Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Spain 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 191: Russia Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Russia Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Russia 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 194: Russia Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Russia Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Russia 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 197: Russia Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Russia Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Russia 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 200: Russia Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Russia Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Russia 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Europe Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Europe 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Europe Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Rest of Europe 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 209: Rest of Europe Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Rest of Europe Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Rest of Europe 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 212: Rest of Europe Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Rest of Europe Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Rest of Europe 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Employer and Workplace Drug Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 216: Asia-Pacific Historic Review for Employer and Workplace Drug Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Asia-Pacific 15-Year Perspective for Employer and Workplace Drug Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Asia-Pacific Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Asia-Pacific 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Asia-Pacific Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Asia-Pacific 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 224: Asia-Pacific Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Asia-Pacific Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Asia-Pacific 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 227: Asia-Pacific Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Asia-Pacific Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Asia-Pacific 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Employer and Workplace Drug Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 230: Australia Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Australia Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Australia 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 233: Australia Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Australia Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Australia 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 236: Australia Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Australia Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Australia 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 239: Australia Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Australia Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Australia 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• INDIA
  • Employer and Workplace Drug Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 242: India Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: India Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: India 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 245: India Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: India Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: India 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 248: India Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: India Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: India 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 251: India Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: India Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: India 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 254: South Korea Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: South Korea Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: South Korea 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 257: South Korea Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: South Korea Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: South Korea 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 260: South Korea Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: South Korea Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: South Korea 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 263: South Korea Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: South Korea Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: South Korea 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Rest of Asia-Pacific Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Rest of Asia-Pacific 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Rest of Asia-Pacific Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Rest of Asia-Pacific 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 272: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Rest of Asia-Pacific Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Rest of Asia-Pacific 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 275: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Rest of Asia-Pacific Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Rest of Asia-Pacific 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Employer and Workplace Drug Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 278: Latin America Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 279: Latin America Historic Review for Employer and Workplace Drug Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Latin America 15-Year Perspective for Employer and Workplace Drug Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 281: Latin America Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Latin America Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Latin America 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 284: Latin America Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Latin America Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Latin America 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 287: Latin America Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Latin America Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Latin America 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 290: Latin America Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Latin America Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Latin America 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 293: Argentina Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Argentina Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Argentina 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 296: Argentina Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Argentina Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Argentina 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 299: Argentina Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Argentina Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Argentina 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 302: Argentina Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Argentina Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Argentina 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 305: Brazil Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Brazil Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Brazil 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 308: Brazil Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Brazil Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Brazil 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 311: Brazil Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Brazil Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Brazil 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 314: Brazil Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Brazil Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Brazil 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 317: Mexico Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Mexico Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Mexico 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 320: Mexico Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Mexico Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Mexico 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 323: Mexico Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Mexico Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Mexico 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 326: Mexico Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Mexico Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Mexico 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Rest of Latin America Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Rest of Latin America 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Rest of Latin America Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Rest of Latin America 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 335: Rest of Latin America Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Rest of Latin America Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Rest of Latin America 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 338: Rest of Latin America Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Rest of Latin America Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Rest of Latin America 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Employer and Workplace Drug Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 341: Middle East Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 342: Middle East Historic Review for Employer and Workplace Drug Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Middle East 15-Year Perspective for Employer and Workplace Drug Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 344: Middle East Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Middle East Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Middle East 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 347: Middle East Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Middle East Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Middle East 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 350: Middle East Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Middle East Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Middle East 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 353: Middle East Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Middle East Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Middle East 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 356: Iran Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Iran Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Iran 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 359: Iran Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Iran Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Iran 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 362: Iran Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Iran Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Iran 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 365: Iran Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Iran Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Iran 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 368: Israel Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Israel Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Israel 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 371: Israel Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Israel Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Israel 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 374: Israel Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Israel Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Israel 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 377: Israel Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Israel Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Israel 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Saudi Arabia Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Saudi Arabia 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Saudi Arabia Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Saudi Arabia 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 386: Saudi Arabia Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Saudi Arabia Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Saudi Arabia 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 389: Saudi Arabia Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Saudi Arabia Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Saudi Arabia 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 392: UAE Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: UAE Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: UAE 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 395: UAE Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: UAE Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: UAE 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 398: UAE Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: UAE Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: UAE 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 401: UAE Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: UAE Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: UAE 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Rest of Middle East Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Rest of Middle East 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Rest of Middle East Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Rest of Middle East 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 410: Rest of Middle East Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Rest of Middle East Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 412: Rest of Middle East 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 413: Rest of Middle East Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Rest of Middle East Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 415: Rest of Middle East 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030
• AFRICA
  • Employer and Workplace Drug Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 416: Africa Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Africa Historic Review for Employer and Workplace Drug Testing by Type - Pre-employment Drug Screens and Post-employment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 418: Africa 15-Year Perspective for Employer and Workplace Drug Testing by Type - Percentage Breakdown of Value Sales for Pre-employment Drug Screens and Post-employment for the Years 2015, 2025 & 2030
  • TABLE 419: Africa Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Africa Historic Review for Employer and Workplace Drug Testing by Drug - Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 421: Africa 15-Year Perspective for Employer and Workplace Drug Testing by Drug - Percentage Breakdown of Value Sales for Opioids, Amphetamine & Methamphetamine, LSD, Others, Alcohol, Cannabis / Marijuana and Cocaine for the Years 2015, 2025 & 2030
  • TABLE 422: Africa Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 423: Africa Historic Review for Employer and Workplace Drug Testing by End-Use - IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 424: Africa 15-Year Perspective for Employer and Workplace Drug Testing by End-Use - Percentage Breakdown of Value Sales for IT / Finance, Manufacturing, Transportation, Construction, Retail & Hospitality, Healthcare, Education and Other Professional Services for the Years 2015, 2025 & 2030
  • TABLE 425: Africa Recent Past, Current & Future Analysis for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 426: Africa Historic Review for Employer and Workplace Drug Testing by Product - Consumables, Instruments, Rapid Testing Devices and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 427: Africa 15-Year Perspective for Employer and Workplace Drug Testing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments, Rapid Testing Devices and Services for the Years 2015, 2025 & 2030

IV. COMPETITION